USD 28.50 Billion
Anticoagulants Market Size, Share, Growth Analysis, By Drug class(Vitamin K Antagonists (VKAs) and Direct Oral Anticoagulants (DOACs)), By Distribution channel(Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35B2093 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
61
|Figures:
75
Anticoagulants Market Insights
Anticoagulants Market size was valued at USD 31.44 Billion in 2023 and is poised to grow from USD 34.68 Billion in 2024 to USD 75.96 Billion by 2032, growing at a CAGR of 10.30% during the forecast period (2025-2032).
The rise in the incidence of severe and critical illnesses worldwide is contributing to the market's expansion. Modern lifestyle changes are the primary cause of the rising frequency of cardiovascular illnesses worldwide. Life-threatening disorders like hypertension, coronary heart disease, and hyperlipidemia are associated with cardiovascular illness of the heart and blood arteries. It may cause strokes or heart attacks. Cardiovascular medications with an anticoagulant component can be used to treat the majority of cardiovascular diseases. Blood clots are more likely to form when these anticoagulants are absent from the medications that are given to patients.
One of the main reasons propelling the growth, according to the global anticoagulants market forecast during the forecast period is the rising prevalence of heart illnesses and the rising need for blood thinners. Anticoagulants underwent a number of research and development advancements prior to being put on the market. Novel medications like NOACs have a very high commercial success rate from the moment of debut. Xarelto and Eliquis are the two most popular coagulants available on the market. The market's expansion is anticipated to be hampered by the widespread availability of generics and other anticipated coagulant launches.
US Anticoagulants Market is poised to grow at sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Flour
Fastest Growth
Flour
Growth Rate
10.30% CAGR
Global Bakery Ingredients Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Anticoagulants Market Segmental Analysis
Global Anticoagulants Market is segmented by drug class, distribution channel, and region. Based on drug class, the market can be segmented into vitamin k antagonists (vkas), and direct oral anticoagulants (doacs). Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Anticoagulants Market Analysis by Drug Class
As per categorization by drug class, the market is classified as NOACs, heparin & LMWH, vitamin K antagonist, and others. Among these, the NOACs earned the largest share and continue to dominate the global anticoagulants market share. Non-vitamin K antagonist oral anticoagulants (NOACs) are revolutionizing the global anticoagulants market through their efficacy, safety, and convenience compared to traditional warfarin. Advances in medical treatment such as direct thrombin inhibitors and factor inhibitors have promoted compliance among patients by avoiding the need for frequent monitoring and food restrictions. This is due to the positive results observed in patients utilizing them, low chances of bleeding episodes and simple dosing causative schedules, making it no surprise that NOACs are most popular among both physicians and patients in the management of thromboembolic diseases.
Heparin and low molecular weight heparins (LMWHs) are poised to be the fastest-growing segment in the global anticoagulants market due to their established efficacy and safety profiles in preventing and treating thromboembolic disorders. The presence of subcutaneous injection along with fast onset of action is highly beneficial in acute care settings, for instance, surgery and intensive care units. Coming to the research, similar and new therapeutic agents are being sought. This has increased the demand towards these drugs. With healthcare systems adopting better management of patient care, and in this case enhancing anticoagulation strategies, the strength of Heparin and LMWHs as well as their range of use will enhance their market in this growing competition.
Anticoagulants Market Analysis by Application
Atrial fibrillation (AF) and heart attacks are significant drivers of growth in the global anticoagulants market share, primarily due to their high prevalence and associated thromboembolic risks. The introduction of new therapies for the treatment of identified factors, particularly NOACs, has allowed for the improvement in the management of patients with AF. The use of new pharmacological agents is much safer and more convenient than previously existing methods. Given the increasing attention on AF as a major contributory factor to the occurrence of strokes, there is also growing demand for the available effective strategies of anticoagulation. Moreover, progress in individualized care comes in handy for that hence enjoying a superior market share. The demographic shift alongside the epidemiological transition, especially increasing occurrences of cardiovascular complications, emphasizes the need for dominance of anticoagulants in the market.
Pulmonary embolism (PE) is emerging as a significant driver of growth in the global anticoagulants market due to its increasing incidence and the urgent need for effective treatment options. The increase in knowledge regarding PE occurring as an extreme complication of DVT has resulted in improvement in its screening and diagnosis, especially among high – risk populations. Contribution of advanced technology in provision of antithrombotic agents like NOACs is coming up with better and safer treatment options which allows for management of the patient at home and reduces rates of in – patient management. Since the providers of health are keen on preventing complications as well as enhancing the outcomes of the patients, the requirement for the drugs which are effective against pulmonary embolism is likely to increase tremendously.
Global Bakery Ingredients Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Anticoagulants Market Regional Insights
North America is dominating the global anticoagulants market outlook due to a combination of high disease prevalence, advanced healthcare infrastructure, and robust research and development initiatives. The increasing prevalence of cardiac disorders, especially atrial fibrillation and thromboembolic complications, has created a need for efficient anticoagulant treatments. Moreover, the presence of a number of large pharmaceutical players allows for faster innovations and marketing of therapies including NOACs. The existing regulatory infrastructure and availability of modern medical technologies assist this region in maintaining its market superiority. In addition, the growth of the global anticoagulants market in North America is further supported by the improved emphasis placed on preventive care by healthcare providers and patients.
The Asia-Pacific region is the fastest-growing in the global anticoagulants market, driven by a rapidly aging population and an increasing prevalence of cardiovascular diseases, including atrial fibrillation and thrombosis. The increasing cost of health care coupled with better availability of advanced medical care is spurring the use of new anticoagulant therapies including NOACs and LMWHs. In addition, there is increasing awareness of thromboembolic disorders and their risks, which will drive screening and early diagnosis of these disorders. In this regard, the region has shown significant growth due to the developing economies of the region investing in the healthcare system and availing of more cutting-edge therapies, making the Asia-Pacific region one of the major markets for the growth of the global anticoagulants market.
Global Bakery Ingredients Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Anticoagulants Market Dynamics
Anticoagulants Market Drivers
Increasing Prevalence of Cardiovascular Diseases
- The growing prevalence of cardiovascular disorders such as atrial fibrillation and thromboembolic conditions is a significant factor driving the growth of the global anticoagulants market trends. As these conditions are beginning to become more prevalent, there is a corresponding growth in the market due to the need for effective therapies aimed at preventing the occurrence of stokes and subsequent management of its complications, such as anticoagulants and other types of stroke management drugs.
Advancements in Anticoagulant Therapies
- The evolution of anticoagulant therapies, especially oral non-vitamin K antagonist anticoagulants (NOACs) is a significant booster for the growth of the industry. The most recent of these agents have better safety profiles, are easier to use, and require less monitoring than traditional therapies, which has improved patient adherence and encouraged their rapid use in clinical practice.
Restraints
Risk of Bleeding Complications
- The threat of blood-related complications due to the use of anticoagulants stands out as one of the key challenges present in the market. Due to potential side effects, especially among the predisposed individuals, health care practitioners may refrain from prescribing such drugs. This worry can limit the widespread acceptance and use of anticoagulants in practice.
Limited Awareness and Education
- Unawareness and lack of education on the advantages and correct pattern of utilization of anticoagulants among health care practitioners and patients alike can limit the growth of the market. Some populations may have lower demand for anticoagulant therapies due to their misconceptions on the thromboembolic diseases and their treatment options leading to under diagnosis and treatment.
Request Free Customization of this report to help us to meet your business objectives.
Anticoagulants Market Competitive Landscape
The competitive landscape of the global anticoagulants market is characterized by the presence of several key players actively engaged in innovation and product development. Leading businesses like Pfizer, Johnson & Johnson, Bristol-Myers Squibb, and Boehringer Ingelheim are in the lead and provide various anticoagulant treatment options. Businesses have turned their attention to the research and growth of new strategies in order to provide better therapeutic approaches and patient survivability and also to cope with satisfying competition that is moving the new oral anticoagulants market positively due to the changes in customer preferences regarding treatment options.
Anticoagulants Market Top Player’s Company Profiles
- Bristol Myers Squibb Company (US)
- Johnson & Johnson (US)
- Boehringer Ingelheim International GmbH (Germany)
- Sanofi S.A. (France)
- Daiichi Sankyo Company, Limited (Japan)
- Novartis International AG (Switzerland)
- Eli Lilly and Company (US)
- AstraZeneca PLC (UK)
- Merck & Co., Inc. (US)
- GlaxoSmithKline PLC (UK)
- Abbott Laboratories (US)
- Aspen Pharmacare Holdings Limited (South Africa)
- Otsuka Holdings Co., Ltd. (Japan)
- Mylan N.V. (US)
- Takeda Pharmaceutical Company Limited (Japan)
- Leo Pharma A/S (Denmark)
- Portola Pharmaceuticals, Inc. (US)
- CSL Limited (Australia)
Anticoagulants Market Recent Developments
- In September 2023, Pfizer recently unveiled a key study result which proved the efficacy of yet another oral anticoagulant, Eteplirsen, in preventing thromboembolic complications in patients with atrial fibrillation. This move is meant to broaden the scope of treatment and enhance patient care, reinforcing Pfizer’s stronghold in the anticoagulant segment.
- In October 2023, Boehringer Ingelheim launched a patient education initiative focusing on its NOAC, Pradaxa. The campaign aims to increase awareness about the importance of adherence to anticoagulant therapy in managing atrial fibrillation and preventing strokes. This initiative underscores the company’s commitment to improving patient care and outcomes.
- In November 2023, The Food and Drug Administration endorsed a new formulation of Bristol-Myers Squibb’s blood thinner, Eliquis, which can be stored for a longer period. This innovation is anticipated to enhance ease of use among health care professionals and patients, cut down on spillage and make it easier to access the drug. The approval also enhances the company’s position in the global anticoagulants industry.
Anticoagulants Key Market Trends
- Growing Adoption of Personalized Medicine: The global anticoagulants market is also seeing trend for implementation of personalized medicine, wherein the provider offering the services is customizing the anticoagulant therapy for each patient, including their genetic makeup as well as other diseases. Therefore, this is done to improve the therapeutic result, and reduction of side effects, thus increasing the efficiency of treatment in general.
- Shift Towards Novel Oral Anticoagulants: The employment of novel oral anticoagulants (NOAC) is gaining popularity among health practitioners as they are easier to manage, and safer than other traditional therapies such as warfarin. This shift in treatment paradigm can be attributed to the growing knowledge of healthcare providers and patients regarding the advantages of NOACs in the effective management of thromboembolic disease.
Anticoagulants Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, in conclusion, the global anticoagulants market is witnessing significant growth due to the rising cases of cardiovascular diseases as well as increasing need for efficient blood-thinning treatment. The rising Introduction of new medicines to the market especially NOACs is changing the treatment landscapes in a way that safer and easier treatment options are made available. However, there are still many challenges like bleeding tendencies and awareness.
The division of the market by drug class and application effectively points out the opportunities for growth, where both old treatments like heparin and new ones for pulmonary embolism or atrial fibrillation play a significant role. Overall, the growth prospects of the global anticoagulants industry are favorable, with several developments taking place and a clear shift towards care that is more focused on the patient.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 28.50 Billion |
| Market size value in 2031 | USD 68.87 Billion |
| Growth Rate | 10.30% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Anticoagulants Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Anticoagulants Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Anticoagulants Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Anticoagulants Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Anticoagulants Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Anticoagulants Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
